HYTN Announces Results of 2024 Annual General and Special Meeting
Vancouver, British Columbia – May 24, 2024 - HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a leader a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds including cannabis, is is pleased to announce the results of its annual general and special meeting of shareholders held on May 23, 2024 (the “AGSM”).
Shareholders voted in favour of all the matters submitted before the AGSM, as set out in the Company’s Notice of Meeting and Information Circular dated April 18, 2024 (the “Circular”), including:
setting the size of the Board to three (3) directors;
re-electing Elliot McKerr, Jason Broome and Eli Dusenbury as directors until the next annual meeting of shareholders of the Company;
reappointing Crowe MacKay LLP as the Company’s auditors for the ensuing year; and
approving the Company’s omnibus equity incentive plan, as more particularly described in the Circular.
“We appreciate the support we have received from shareholders at this year’s AGSM, and we are looking forward to the upcoming year as we continue to pursue our ambitious goals”, states Elliot McKerr, CEO.
About HYTN Innovations Inc.
HYTN formulates, manufactures, markets, and sells premium products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids. HYTN's mission is to become the top provider of these products in all markets where such products are federally regulated. To achieve this, the Company focuses on identifying market opportunities and quickly bringing its innovative products to market through its elevated development platform.
For more information, contact:
Elliot McKerr
Chief Executive Officer
1.866.590.9289 HYTN
Investor Relations
1.866.590.9289
investments@hytn.life
Certain information contained herein may constitute forward-looking statements that involve risks and uncertainties. Readers are cautioned not to place undue reliance on forward-looking statements, including, but not limited to, statements regarding the Company’s pursuit of its ambitious goals in the upcoming year. Factors that could cause actual results to vary from forward-looking statements or may affect the operations, performance, development, and results of the Company’s business include, among other things: the Company's ability to generate sufficient cash flow from operations to meet its current and future obligations; the Company's ability to access sources of debt and equity capital; competitive factors, pricing pressures, and supply and demand in the Company’s industry; general economic and business conditions; and the effects and impacts of the COVID-19 pandemic, the extent and duration of which are uncertain at this time, on the Company's business and general economic and business conditions and markets. Any statements that are not statements of historical fact are deemed to be forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and, except to the extent required by applicable law, the Company assumes no obligation to update or revise forward-looking statements made herein or otherwise, whether because of new information, future events, or otherwise. The forward-looking statements contained in this news release are expressly qualified by this cautionary note.
The Canadian Securities Exchange (CSE) has not reviewed, approved, or disapproved the contents of this press release.
